Literature DB >> 15253705

Multiple facets of macrophages in renal injury.

David C Kluth1, Lars-Peter Erwig, Andrew J Rees.   

Abstract

Macrophage infiltration is a common feature of renal disease and their presence has been synonymous with tissue damage and progressive renal failure. More recently work has focused on the heterogeneity of macrophage activation and in particular their ability to curtail inflammation and restore normal function. This has led to the view that it is macrophage function rather than their number that is important in determining the outcome of inflammatory disease. This review will focus on the pathways that regulate macrophage infiltration and activation and how these could be manipulated to control renal inflammatory disease. In particular, the ability of specific cell surface receptors and intracellular signaling pathways to control macrophage activation and how macrophages can be genetically manipulated to develop properties that favor resolution over ongoing injury.

Entities:  

Mesh:

Year:  2004        PMID: 15253705     DOI: 10.1111/j.1523-1755.2004.00773.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  40 in total

1.  Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo.

Authors:  Heather M Wilson; Salah Chettibi; Christian Jobin; David Walbaum; Andrew J Rees; David C Kluth
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

Review 2.  Macrophages in hepatitis B and hepatitis C virus infections.

Authors:  Mathis Heydtmann
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

3.  Nitric oxide is an important mediator of renal tubular epithelial cell death in vitro and in murine experimental hydronephrosis.

Authors:  Tiina Kipari; Jean-Francois Cailhier; David Ferenbach; Simon Watson; Kris Houlberg; David Walbaum; Spike Clay; John Savill; Jeremy Hughes
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  Blockade of the kinin B1 receptor ameloriates glomerulonephritis.

Authors:  Julie Klein; Julien Gonzalez; Stéphane Decramer; Flavio Bandin; Eric Neau; David J Salant; Peter Heeringa; Joao-Bosco Pesquero; Joost-Peter Schanstra; Jean-Loup Bascands
Journal:  J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 10.121

5.  Genetic loci modulate macrophage activity and glomerular damage in experimental glomerulonephritis.

Authors:  Jacques Behmoaras; Jennifer Smith; Zelpha D'Souza; Gurjeet Bhangal; Ratana Chawanasuntoropoj; Frederick W K Tam; Charles D Pusey; Timothy J Aitman; H Terence Cook
Journal:  J Am Soc Nephrol       Date:  2010-05-20       Impact factor: 10.121

6.  Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity.

Authors:  Li-Jun Ma; Bridgette A Corsa; Jun Zhou; HaiChun Yang; HaiJing Li; Yi-Wei Tang; Vladimir R Babaev; Amy S Major; MacRae F Linton; Sergio Fazio; Tracy E Hunley; Valentina Kon; Agnes B Fogo
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-02

7.  Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis.

Authors:  Ling Zheng; Raja Sinniah; Stephen I-Hong Hsu
Journal:  J Histochem Cytochem       Date:  2008-02-18       Impact factor: 2.479

8.  Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis.

Authors:  L M McIntosh; J L Barnes; V L Barnes; J R McDonald
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

Review 9.  Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease?

Authors:  J D Paladino; J R Hotchkiss; H Rabb
Journal:  Microvasc Res       Date:  2008-09-11       Impact factor: 3.514

10.  Effect of sodium overload on renal function of offspring from diabetic mothers.

Authors:  Luigi Rocco; Frida Zaladek Gil; Thaís Maria da Fonseca Pletiskaitz; Maria de Fátima Cavanal; Guiomar Nascimento Gomes
Journal:  Pediatr Nephrol       Date:  2008-06-24       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.